{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:38:46Z","timestamp":1775885926298,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Medical interns are at high risk of acquiring Hepatitis B Virus (HBV) infection during their training. HBV vaccination is the most effective measure to reduce the global incidence of HBV. The duration of protection after HBV vaccination is still controversial. We aimed to determine the prevalence of protective anti-HBs levels among medical interns who had received compulsory hepatitis B vaccination in infancy, and to assess the anamnestic response of those subjects with non-protective antibodies titers, to a booster dose of the vaccine. We conducted a cross-sectional study on 519 medical interns in 2022. We examined their immunization status and records. Blood samples were collected and qualitative testing of Hepatitis B surface antigen (HBsAg), and quantitative testing of Hepatitis B surface antibody (anti-HBs) were performed. For medical interns whose titers were \u02c2\u200910 mIU\/mL, a booster dose of the vaccine was given, followed by repeat testing of anti-HBs 2 months later. About 304 (58.6%) of the medical interns revealed titers higher than or equal 10 mIU\/mL. About (44.93%) of male medical interns showed an immunity level below 10 mIU\/mL. However, (43.91%) of female medical interns had an antibody titer of 100 mIU\/mL or higher. All subjects who got a booster dose presented a titer level of 10 mIU\/mL 2 months later. About (41.4%) of our medical interns enrolled in the study had anti-HBs titer \u02c2 10 mIU\/mL. This raises the importance of establishing a screening protocol and offering booster dose for those at risk to protect them against the high risk of infection.<\/jats:p>","DOI":"10.1038\/s41598-025-00055-w","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:49:50Z","timestamp":1746784190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-HBs persistence and anamnestic response among medical interns vaccinated in infancy"],"prefix":"10.1038","volume":"15","author":[{"given":"Nesrine Fathi","family":"Hanafi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashwa Naguib","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada Abdelwahed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani Ali","family":"El-Kholy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"ElShafei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara AbdelAziz","family":"Essa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"55_CR1","unstructured":"World Health Organization (WHO). Occupational Health, Health Workers and Health Worker Occupational Health. Available online: http:\/\/www.who.int\/occupational_health\/topics\/hcworkers\/en\/"},{"issue":"27(26","key":"55_CR2","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.3748\/wjg.v27.i26.4018","volume":"14","author":"MB Pisano","year":"2021","unstructured":"Pisano, M. B. et al. Viral hepatitis update: Progress and perspectives. World J. Gastroenterol. 14 (27(26), 4018\u20134044 (2021).","journal-title":"World J. Gastroenterol."},{"key":"55_CR3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4254\/wjh.v7.i3.488","volume":"7","author":"JD Lewis","year":"2015","unstructured":"Lewis, J. D., Enfield, K. B. & Sifri, C. D. Hepatitis B in healthcare workers: Transmission events and guidance for management. World J. Hepatol. 7, 488\u2013497 (2015).","journal-title":"World J. Hepatol."},{"issue":"9","key":"55_CR4","doi-asserted-by":"publisher","first-page":"e6025","DOI":"10.5812\/hepatmon.6025","volume":"12","author":"G Grosso","year":"2012","unstructured":"Grosso, G. et al. Long-term persistence of seroprotection by hepatitis B vaccination in healthcare workers of Southern Italy. Hepat. Mon. 12 (9), e6025 (2012).","journal-title":"Hepat. Mon"},{"issue":"23(1","key":"55_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12879-023-08110-5","volume":"10","author":"A Azzam","year":"2023","unstructured":"Azzam, A. et al. Seroprevalence of hepatitis B virus surface antigen (HBsAg) in Egypt (2000\u20132022): A systematic review with meta-analysis. BMC Infect. Dis. 10 (23(1), 151 (2023).","journal-title":"BMC Infect. Dis."},{"key":"55_CR6","first-page":"1","volume":"60","author":"Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC). Immunization of healthcare personnel: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 60, 1\u201345 (2011).","journal-title":"MMWR Recomm Rep."},{"key":"55_CR7","unstructured":"WHO prequalified vaccines. December (2023). Available at https:\/\/extranet.who.int\/prequal\/vaccines\/list-prequalified-vaccines accessed on 14."},{"key":"55_CR8","unstructured":"World Health Organization (WHO). Immunization coverage facts (2023). Available from URL: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage accessed on 14 December 2023."},{"key":"55_CR9","doi-asserted-by":"crossref","unstructured":"Chen, D. S. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. J. Hepatol. 50(4), 805\u2013816 (2009).","DOI":"10.1016\/j.jhep.2009.01.002"},{"issue":"4","key":"55_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1128\/CVI.00694-12","volume":"20","author":"P Spradling","year":"2013","unstructured":"Spradling, P., Xing, J., Williams, R., Faleafaga, Y. & Dulski, T. Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: Association of detectable residual antibodies and response to a single HBV challenge dose. Clin. Vaccine Immunol. 20 (4), 559\u2013561 (2013).","journal-title":"Clin. Vaccine Immunol."},{"issue":"9","key":"55_CR11","doi-asserted-by":"publisher","first-page":"e22223","DOI":"10.5812\/hepatmon.22223","volume":"14","author":"H Saffar","year":"2014","unstructured":"Saffar, H., Saffar, M., Ajami, A., Khalilian, A. & Esfandabad, K. Long-term T-cell-mediated Immunologic memory to hepatitis B vaccine in young adults following neonatal vaccination. Hepat. Mon. 14 (9), e22223 (2014).","journal-title":"Hepat. Mon"},{"key":"55_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","volume":"355","author":"European Consensus Group on Hepatitis B Immunity","year":"2000","unstructured":"European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity?. Lancet 355, 561\u2013565 (2000).","journal-title":"Lancet"},{"key":"55_CR13","doi-asserted-by":"crossref","unstructured":"La Torre, G. et al. Knowledge, attitude and behaviours towards recommended vaccinations among healthcare workers. Healthcare 5, 13 (2017).","DOI":"10.3390\/healthcare5010013"},{"key":"55_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/21645515.2017.1264795","volume":"13","author":"L Roman\u00f2","year":"2017","unstructured":"Roman\u00f2, L. et al. Persistence of immunity 18\u201319 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy. Hum. Vaccin. Immunother. 13, 981\u2013985 (2017).","journal-title":"Hum. Vaccin. Immunother"},{"issue":"21(1","key":"55_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1186\/s12879-021-06913-y","volume":"2","author":"EN Anutebeh","year":"2021","unstructured":"Anutebeh, E. N. et al. Immune response to hepatitis B vaccine following complete immunization of children attending two regional hospitals in the Southwest region of Cameroon: A cross-sectional study. BMC Infect. Dis. 2 (21(1), 1205 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"20\u201322","key":"55_CR16","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/S0264-410X(01)00005-6","volume":"19","author":"A Faustini","year":"2001","unstructured":"Faustini, A. et al. Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy. Vaccine 19 (20\u201322), 2812\u20132818 (2001).","journal-title":"Vaccine"},{"issue":"12","key":"55_CR17","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.4161\/hv.34393","volume":"10","author":"M Bagheri-Jamebozorgi","year":"2014","unstructured":"Bagheri-Jamebozorgi, M. et al. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with Recombinant hepatitis B vaccine at infancy. Hum. Vaccin. Immunother. 10 (12), 3731\u20133736 (2014).","journal-title":"Hum. Vaccin. Immunother"},{"issue":"60(3","key":"55_CR18","first-page":"E184","volume":"30","author":"A Stefanati","year":"2019","unstructured":"Stefanati, A. et al. Long-term persistency of hepatitis B immunity: An observational cross-sectional study on medical students and resident Doctors. J. Prev. Med. Hyg. 30 (60(3), E184\u2013E190 (2019).","journal-title":"J. Prev. Med. Hyg."},{"issue":"22","key":"55_CR19","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.4254\/wjh.v7.i22.2418","volume":"7","author":"II Salama","year":"2015","unstructured":"Salama, I. I. et al. Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter National project. World J. Hepatol. 7 (22), 2418\u20132426 (2015).","journal-title":"World J. Hepatol."},{"key":"55_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12995-015-0083-4","volume":"10","author":"M Lamberti","year":"2015","unstructured":"Lamberti, M. et al. Vaccination against hepatitis B virus: Are Italian medical students sufficiently protected after the public vaccination program? J. Occup. Med. Toxicol. 10, 41 (2015).","journal-title":"J. Occup. Med. Toxicol."},{"key":"55_CR21","doi-asserted-by":"publisher","unstructured":"Annisa, Zain, L. H. & Ricke, L. Protection status against hepatitis B infection assessed from anti-HBs level, history of vaccination and history of infection based on anti-HBc in medical students. IOP Conf. Ser. Earth Environ. Sci. 125, 012104. https:\/\/doi.org\/10.1088\/1755-1315\/125\/1\/012104 (2018).","DOI":"10.1088\/1755-1315\/125\/1\/012104"},{"issue":"3","key":"55_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s15010-008-7410-y","volume":"37","author":"F Hofmann","year":"2009","unstructured":"Hofmann, F. & Kralj, N. Criteria for successful hepatitis B vaccination in adults: Results of a case study. Infection 37 (3), 266\u2013269 (2009).","journal-title":"Infection"},{"key":"55_CR23","unstructured":"Publication, W. H. O. & Hepatitis, B. vaccines: WHO position paper\u2014July 2017; 27, 369\u2013392. Available at http:\/\/www.who.int\/wer"},{"key":"55_CR24","doi-asserted-by":"crossref","unstructured":"Are booster immunizations. Needed for lifelong hepatitis B immunity? European consensus group on hepatitis B immunity. Lancet 355 (9203), 561\u2013565 (2000).","DOI":"10.1016\/S0140-6736(99)07239-6"},{"issue":"4","key":"55_CR25","first-page":"329","volume":"64","author":"S Chaudhari","year":"2008","unstructured":"Chaudhari, S., Bhagat, C., Shah, T. & Misra, S. Antibody to hepatitis B surface antigen in vaccinated health care workers. MJAFI 64 (4), 329\u2013332 (2008).","journal-title":"MJAFI"},{"key":"55_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/1110-2098.179003","volume":"29","author":"RE El Bahnasy","year":"2016","unstructured":"El Bahnasy, R. E., Abu Salem, M. E., El Shazly, H. M. & Morad, W. S. Predictors of poor response to the hepatitis B vaccine among healthcare workers at the National liver Institute hospital. Menoufia Med. J. 29, 131\u2013135 (2016).","journal-title":"Menoufia Med. J."},{"key":"55_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/vaccines9040323","volume":"9","author":"S Cocchio","year":"2021","unstructured":"Cocchio, S. et al. Persistence of anti-Hbs after up to 30 years in health care workers vaccinated against hepatitis B virus. Vaccines 9, 323 (2021).","journal-title":"Vaccines"},{"issue":"4","key":"55_CR28","first-page":"210","volume":"2","author":"K Pavani","year":"2015","unstructured":"Pavani, K., Srinivas, M. S., Samhitha, M., Vinayaraj, E. V. & Dass, S. Immune response to hepatitis B vaccine in health care workers in tertiary care hospital in South India. IJ Microbiol. Res. 2 (4), 210\u2013213 (2015).","journal-title":"IJ Microbiol. Res."},{"key":"55_CR29","first-page":"179","volume":"22","author":"F Zamani","year":"2011","unstructured":"Zamani, F., Fallahian, F., Hashemi, F., Shamsaei, Z. & Alavian, S. M. Immune response to hepatitis B vaccine in health care workers. Saudi J. Kidney Dis. Transpl. 22, 179\u2013184 (2011).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"issue":"17(1","key":"55_CR30","doi-asserted-by":"publisher","first-page":"e0262126","DOI":"10.1371\/journal.pone.0262126","volume":"21","author":"M Ocan","year":"2022","unstructured":"Ocan, M. et al. Antibody levels and protection after hepatitis B vaccine in adult vaccinated healthcare workers in Northern Uganda. PLoS One. 21 (17(1), e0262126 (2022).","journal-title":"PLoS One"},{"key":"55_CR31","unstructured":"Centers for Disease Control and Prevention. Interpretation of Hepatitis B Serologic Test Results. https:\/\/www.cdc.gov\/hepatitis\/hbv\/interpretationOfHepBSerologicResults.html. Last accessed on 7 December 2023."},{"issue":"19(1","key":"55_CR32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12879-019-4134-9","volume":"30","author":"YL Zhao","year":"2019","unstructured":"Zhao, Y. L. et al. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination. BMC Infect. Dis. 30 (19(1), 482 (2019).","journal-title":"BMC Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00055-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00055-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00055-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:49:59Z","timestamp":1746784199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00055-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00055-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Research Ethics Committee of Alexandria University Medical School (Federal Wide serial number: 0306425). The research concept and aim were explained to all participating medical interns, and informed consent was signed before participating in the study. All the methods were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent for publication"}},{"value":"More date regarding specialty and history of sharp injuries would be considered in further researches that may be guided by this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Recommendations"}}],"article-number":"16213"}}